NEUROSCIENTIFIC BIOPHARMACEU

0.130

0.000

成交量：4,857.00

成交額：631.00

市值：4,323.48萬

市盈率：-10.32

高：0.130

開：0.130

低：0.130

收：0.130

52周最高：0.260

52周最低：0.034

股本：3.33億

流通股本：2.43億

量比：0.05

換手率：0.00%

股息：- -

股息率：- -

每股收益(TTM):-0.013

每股收益(LYR):-0.013

淨資產收益率：-16.65%

總資產收益率：-11.21%

市淨率：2.57

市盈率(LYR):-10.33

資料載入中...

總覽公司新聞資訊公告

概念

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

收購MSC幹細胞療法技術引發股價暴漲 Neuroscientific Biopharmaceuticals (ASX:NSB) 加速克羅恩病臨試研究

澳洲财经见闻

·

2025/07/19

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NSB.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"NSB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NSB.AU\",,,,,undefined,":{"symbol":"NSB.AU","market":"AU","secType":"STK","nameCN":"NEUROSCIENTIFIC BIOPHARMACEU","latestPrice":0.13,"timestamp":1770700320000,"preClose":0.13,"halted":0,"volume":4857,"delay":0,"changeRate":0,"nameEN":"NEUROSCIENTIFIC BIOPHARMACEU","floatShares":243142540,"shares":332575706,"eps":-0.0126,"marketStatus":"已收盤","change":0,"latestTime":"02-10 16:12:00 AEDT","open":0.13,"high":0.13,"low":0.13,"amount":631,"amplitude":0,"askPrice":0.135,"askSize":56660,"bidPrice":0.13,"bidSize":104769,"shortable":3,"etf":0,"ttmEps":-0.0126,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1770764400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.13,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":0.050377,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NSB.AU\",,,,,undefined,":{"symbol":"NSB.AU","floatShares":243142540,"roa":"-11.21%","roe":"-16.65%","lyrEps":-0.012583,"volumeRatio":0.050377,"shares":332575706,"dividePrice":0,"high":0.13,"amplitude":0,"preClose":0.13,"low":0.13,"week52Low":0.034,"pbRate":"2.57","psRate":"260.33","week52High":0.26,"institutionHeld":0,"latestPrice":0.13,"committee":0.29802,"eps":-0.0126,"divideRate":0,"volume":4857,"delay":0,"ttmEps":-0.0126,"open":0.13,"prevYearClose":0.11,"prevWeekClose":0.13,"prevMonthClose":0.14,"prevQuarterClose":0.11,"fiveDayClose":0.135,"twentyDayClose":0.115,"sixtyDayClose":0.145},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NSB.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NSB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NSB.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2552154364","title":"收購MSC幹細胞療法技術引發股價暴漲 Neuroscientific Biopharmaceuticals (ASX:NSB) 加速克羅恩病臨試研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2552154364","media":"澳洲财经见闻","labels":["corporation","productRelease","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552154364?lang=zh_tw&edition=fundamental","pubTime":"2025-07-19 10:36","pubTimestamp":1752892572,"startTime":"0","endTime":"0","summary":"神经免疫疾病生物医学创新公司Neuroscientific Biopharmaceuticals Ltd (ASX股票代…","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://afndaily.com/%e6%94%b6%e8%b4%admsc%e5%b9%b2%e7%bb%86%e8%83%9e%e7%96%97%e6%b3%95%e6%8a%80%e6%9c%af%e5%bc%95%e5%8f%91%e8%82%a1%e4%bb%b7%e6%9a%b4%e6%b6%a8-neuroscientific-biopharmaceuticals-asxnsb-%e5%8a%a0/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,productRelease,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NSB.AU","MSC","BK7067","BK4150","BK4575"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NSB.AU\",params:#limit:6,delay:true,,,undefined,":[]}}